TTrialPathMatch Me to Trials
← Back to trials
RecruitingOsteoarthritis, HipRheumatoid Arthritis

Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis

Eligible age

18–74 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.

Sponsor: University of Turku

You may qualify if…

  • ✓ Cases: Adult patients with osteoarthritis in the hip joint and who are going through an elective total hip arthroplasty.
  • ✓ Controls: Non-arthritis adult patients who are going through a trauma-based emergency total hip arthroplasty.
  • ✓ \----
  • ✓ Adult patients with rheumatoid arthritis in the hip joint and who are going through an elective total hip arthroplasty.
  • ✓ \----

You may not qualify if…

  • ✕ The body mass index must be below 35
  • ✕ Age \< 18 or \> 74
  • ✕ The OA patients may not have diabetes, rheumatoid arthritis (RA), or metabolic syndrome.
  • ✕ For the Rheumatoid sub-study, the exclusion criteria are the same as above except for the RA.

Source: ClinicalTrials.gov · NCT05278520 · last updated 2025-08-24

Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthriti · TrialPath